Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-29 10:40 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Frazier Life Sciences Public Fund L.P. | 2,631,713 5.4% | 2,631,713 (New Position) | View |
| 2024-02-14 08:19 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,805,000 5.9% | -1,430,000 (-33.77%) | View |
| 2024-02-13 5:12 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,802,081 7.99% | 213,159 (+5.94%) | View |
| 2024-02-06 3:54 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | ACORN BIOVENTURES L.P. | 2,934,496 6.2% | 194,561 (+7.10%) | View |
| 2024-01-30 4:08 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | MILLENNIUM MANAGEMENT LLC | 3,164,249 6.7% | 487,336 (+18.21%) | View |
| 2023-09-01 10:18 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | ACORN BIOVENTURES L.P. | 2,739,935 5.8% | 2,739,935 (New Position) | View |
| 2023-02-14 08:30 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 4,235,000 9.28% | 2,185,000 (+106.59%) | View |
| 2023-02-09 11:30 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,588,922 7.86% | -91,265 (-2.48%) | View |
| 2023-02-07 4:33 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | GOLDMAN SACHS GROUP INC GS | 396,136 0.9% | -1,701,511 (-81.12%) | View |
| 2023-01-19 4:19 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | MILLENNIUM MANAGEMENT LLC | 2,676,913 5.8% | 439,214 (+19.63%) | View |
| 2022-12-12 6:35 pm Purchase | 13D | PUMA BIOTECHNOLOGY INC PBYI | AUERBACH ALAN H | 10,195,990 20.5% | 848,713 (+9.08%) | View |
| 2022-07-08 4:56 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | BlackRock Inc. BLK | 1,903,137 4.2% | -1,301,100 (-40.61%) | View |
| 2022-03-14 8:24 pm Purchase | 13D | PUMA BIOTECHNOLOGY INC PBYI | AUERBACH ALAN H | 9,347,277 21% | 2,089,066 (+28.78%) | View |
| 2022-02-14 09:35 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,050,000 5.01% | -505,000 (-19.77%) | View |
| 2022-02-11 4:21 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Flynn James E | 0 0% | -3,959,741 (Position Closed) | View |
| 2022-02-10 08:32 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,680,187 9% | 283,498 (+8.35%) | View |
| 2022-02-10 06:31 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | STATE STREET CORP STT | 578,090 1.41% | -1,663,947 (-74.22%) | View |
| 2022-02-08 4:43 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | GOLDMAN SACHS GROUP INC GS | 2,097,647 5.1% | 2,097,647 (New Position) | View |
| 2022-02-02 7:11 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | BlackRock Inc. BLK | 3,204,237 7.8% | 208,222 (+6.95%) | View |
| 2022-01-14 4:08 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | MILLENNIUM MANAGEMENT LLC | 2,237,699 5.5% | 2,237,699 (New Position) | View |